Xiaoyun Zhang

机构：Hebei Medical University, Sichuan University, Tianjin Medical University Cancer Institute and Hospital, West China Hospital of Sichuan University, Jiuquan Iron & Steel (China), Fourth Hospital of Hebei Medical University, Guangxi University of Chinese Medicine, Ruikang Affiliated Hospital of Guangxi Medical University · ORCID：0000-0003-1257-379X

发表论文 74 篇 · 总被引 842 次 · h-index 14

代表论文

• Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer? (2022 · BMC Cancer · 被引 14)
• Lumbar disc herniation reabsorption: a review of clinical manifestations, mechanisms, and conservative treatments (2025 · Frontiers in Medicine · 被引 8)
• Mitochondrial displacement loop region single nucleotide polymorphisms and mitochondrial DNA copy number associated with risk of ankylosing spondylitis (2023 · International Journal of Rheumatic Diseases · 被引 8)
• Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers (2023 · Frontiers in Oncology · 被引 8)
• Injectable Granular Hydrogels as Colloidal Assembly Microreactors for Customized Structural Colored Objects (2022 · Angewandte Chemie · 被引 8)
• Pulmonary Arterial Hypertension Induced by Immune Checkpoint Inhibitor Combined Therapy in a Patient with Intrahepatic Cholangiocarcinoma: A Case Report. (2023 · PubMed · 被引 7)